Axcelead has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with technology advancements.

Axcelead is focused on accelerating the discovery and development of high-value drug classes through our end-to-end platform, enabling our biotechnology and pharmaceutical partners to deliver benefit to patients around the world.

NVIDIA Inception will allow Axcelead to accelerate its drug discovery processes by providing specialized AI tools and resources. Access to NVIDIA’s cutting-edge GPUs and deep learning expertise will enable us to refine and expand our computational drug discovery platforms, enhancing our capabilities in predictive analytics and molecular modeling.

The program will also offer Axcelead the opportunity to collaborate with industry-leading experts and other AI-driven organizations.

※NVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every NVIDIA Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support, and technology assistance, which provides startups with the fundamental tools to help them grow.